Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
08/31/1993 | US5240832 Culturing cells transformed with vectors to produce thyroid stimulating hormone |
08/31/1993 | US5240831 Genetic engineering |
08/31/1993 | US5240703 Attenuated, genetically-engineered pseudorabies virus s-prv-155 and uses thereof |
08/31/1993 | CA1321768C Enzyme immobilization and bioaffinity separations with perfluorocarbon polymer-based supports |
08/31/1993 | CA1321766C Process for producing cell having high productivity of protein and process for preparing protein by using the cell |
08/31/1993 | CA1321765C Immunodiagnostic assays using chimeric antigens |
08/31/1993 | CA1321764C Dna sequence to target proteins to the mammary gland for efficient secretion |
08/31/1993 | CA1321763C Monoclonal antibody specific to human pancreatic phospholipase a |
08/31/1993 | CA1321746C Method and kit for assaying gene expressions |
08/29/1993 | CA2089966A1 Antigen binding proteins and methods for their production |
08/29/1993 | CA2089045A1 Differential screening protocol that allows the detection of marginally induced or repressed mrnas |
08/28/1993 | CA2090571A1 Cephalosporin c acylase |
08/26/1993 | CA2089423A1 Dna fragment sizing and sorting by laser-induced fluorescence |
08/25/1993 | EP0586375A4 Detergent compositions containing substantially pure eg iii cellulase. |
08/25/1993 | EP0557076A1 Selective removal of N-terminal extensions from folded insulin precursors using dipeptidyl-aminopeptidase-1 |
08/25/1993 | EP0556699A1 Novel fungal strains and use thereof in antibiotic production |
08/25/1993 | EP0556651A2 Human neuronal beta-subunits of voltage-dependent calcium channels and use of the same |
08/25/1993 | EP0556521A1 Sample processing using disinfectant |
08/25/1993 | EP0556496A2 Antibodies against tumor-associated mucin glycoprotein |
08/25/1993 | EP0556434A2 Process for economically producing a protein by using silkworms |
08/25/1993 | EP0556395A1 Novel cytokine |
08/25/1993 | EP0556345A1 Retroviral vectors useful for gene therapy. |
08/25/1993 | EP0556339A1 Chinese hamster ovary cell retrovirus-like c particles |
08/25/1993 | EP0556333A1 Avirulent microbes and uses therefor: salmonella typhi |
08/25/1993 | EP0556330A1 Method of targeting dna |
08/25/1993 | EP0556320A1 Monoclonal antibodies to hepatitis c virus and method for using same |
08/25/1993 | EP0556301A1 Incorporation of multiple reporter groups on synthetic oligonucleotides |
08/25/1993 | EP0556292A1 Hepatitis c virus asialoglycoproteins |
08/25/1993 | EP0556288A1 Test for virulent revertants in attenuated live vaccines |
08/25/1993 | EP0556242A1 Expression of genes in transgenic plants |
08/25/1993 | EP0556231A1 Method and composition for controlling proliferation of cells |
08/25/1993 | EP0556207A1 Modified human tnfalpha (tumor necrosis factor alpha) receptor |
08/25/1993 | EP0556197A1 Prolonging expression of polynucleotides introduced into a cell |
08/25/1993 | EP0556182A1 Dna capable of site-specific integration into mycobacteria |
08/25/1993 | EP0556178A1 Use of protease nexin-i to mediate wound healing |
08/25/1993 | EP0556171A1 Growth hormone antagonists |
08/25/1993 | EP0555405A4 Specific detection of antibodies to human t-cell leukemia viruses |
08/25/1993 | EP0199801B1 Methods for protein binding enzyme complementation assays |
08/25/1993 | CN2140902Y Intelligent gene amplification instrument |
08/25/1993 | CA2090278A1 Prostaglandin e receptors, their dna and production |
08/25/1993 | CA2089351A1 Gaucher's disease: detection of a new mutation in intron 2 of the glucocerebrosidase gene |
08/24/1993 | US5239066 Isolated nucleic acid having transcriptional and translational initiation and termination regions linked with yversinia ail gene encoding region |
08/24/1993 | US5239065 Polypeptides; stability, free side effects; antiinflammatory agents |
08/24/1993 | US5239060 Muscular dystrophy protein, dystrophin |
08/24/1993 | US5238916 Stimulates proliferation of mesodermal cells and growth of capillaries, promotes tissue repair |
08/24/1993 | US5238836 Genetic engineering; isolated DNA sequences |
08/24/1993 | US5238834 CDNA cloning vectors |
08/24/1993 | US5238833 Molecular cloning and expression in industrial Bacillus species |
08/24/1993 | US5238822 Gene expression in yeast cells |
08/24/1993 | US5238820 Multiply-amplifiable vectors for high level expression of exogenuos DNA |
08/24/1993 | CA1321563C Light inducible promoter |
08/19/1993 | WO1993016197A1 Nucleotide sequences and materials and methods for the diagnosis of myotonic dystrophy |
08/19/1993 | WO1993016187A1 Plant carrying genes coding for enzymes of the phytosterol biosynthesis pathway and process for the production of same |
08/19/1993 | WO1993016186A1 Hybrid dna that codes for a subunit of a bacterial toxin with a hemolysin |
08/19/1993 | WO1993016185A2 Biosynthetic binding protein for cancer marker |
08/19/1993 | WO1993016184A1 Design, cloning and expression of humanized monoclonal antibodies against human interleukin-5 |
08/19/1993 | WO1993016183A1 Cyclophilin associated membrane proteins dna sequences |
08/19/1993 | WO1993016182A1 Cloning and functional expression of cholecystokinin receptor-encoding dna |
08/19/1993 | WO1993016181A1 A 90k tumor-associated antigen, ir-95 |
08/19/1993 | WO1993016179A1 MAMMALIAN Sos - A REGULATOR/EFFECTOR OF TYROSINE KINASE SIGNALLING |
08/19/1993 | WO1993016178A2 Sequences characteristic of human gene transcription product |
08/19/1993 | WO1993016177A1 Homogenotization of gene-targeting events |
08/19/1993 | WO1993016172A1 Mycobacterial species-specific reporter mycobacteriophages |
08/19/1993 | WO1993016170A1 Genetically engineered transmissible hypovirulence |
08/19/1993 | WO1993016158A1 Detergent compositions with high activity cellulase and quaternary ammonium compounds |
08/19/1993 | WO1993016099A2 Dna sequences encoding novel growth/differentiation factors |
08/19/1993 | WO1993016096A1 Recombinant gibberellin dna and uses thereof |
08/19/1993 | WO1993016095A1 Oligothionucleotides |
08/19/1993 | WO1993016094A2 Applications of fluorescent n-nucleosides and fluorescent structural analogs of n-nucleosides |
08/19/1993 | WO1993015769A1 Mutagenesis testing using transgenic non-human animals carrying test dna sequences |
08/19/1993 | WO1993015755A1 Protease-resistant thrombomodulin analogs |
08/19/1993 | WO1993015750A1 Use of synthetic peptides to induce tolerance to pathogenic t and b cell epitopes of autoantigens |
08/19/1993 | WO1993015743A1 Novel gene therapies employing antisense constructs |
08/19/1993 | WO1993015608A1 Prevention of retinal injury and degeneration by specific factors |
08/19/1993 | WO1993015599A1 Polyphenol oxidase |
08/19/1993 | DE4219696A1 Hybrid-dna, plasmide, oligohybridpeptid und impfstoff Hybrid dna, plasmids, and oligohybridpeptid vaccine |
08/19/1993 | DE4204103A1 New gamma-amino butyric acid permease gene - for growth inhibition of microbial or plant cells or as selectable marker |
08/19/1993 | CA2372813A1 Biosynthetic binding protein for cancer marker |
08/19/1993 | CA2130081A1 Mutagenesis testing using transgenic non-human animals carrying test dna sequences |
08/19/1993 | CA2129517A1 Recombinant gibberellin dna and uses thereof |
08/19/1993 | CA2129445A1 Design, cloning and expression of humanized monoclonal antibodies against human interleukin-5 |
08/19/1993 | CA2129370A1 Protease-resistant thrombomodulin analogs |
08/19/1993 | CA2129364A1 Oligothionucleotides |
08/19/1993 | CA2129351A1 Use of synthetic peptides to induce tolerance to pathogenic t and b cell epitopes of autoantigens |
08/19/1993 | CA2129105A1 Applications of fluorescent n-nucleosides and fluorescent structural analogs of n-nucleosides |
08/19/1993 | CA2129034A1 Mycobacterial species-specific reporter mycobacteriophages |
08/19/1993 | CA2089541A1 Selective removal of n-terminal extensions from folded insulin precursors using dipeptidyl-aminopeptidase-1 |
08/18/1993 | EP0556160A2 Insecticidal toxins from plectreurys tristis |
08/18/1993 | EP0556111A1 Hybrid protein complexes, their process of preparation, and their applications as an agent in diagnostic and in the therapeutic field or as a reagent relevant in medical approaches |
08/18/1993 | EP0556106A2 Antibody binding to human aldose reductase and its uses |
08/18/1993 | EP0555989A1 TGF-beta induced gene and protein |
08/18/1993 | EP0555894A1 Whooping cough vaccine |
08/18/1993 | EP0555880A2 The CD40CR receptor and ligands therefor |
08/18/1993 | EP0555798A1 Hydrated celite and purification of DNA |
08/18/1993 | EP0555785A1 Smooth muscle mitogen and DNA coding therefor |
08/18/1993 | EP0555661A1 Process for production of L-lysine by fermentation of coryneform bacteria |
08/18/1993 | EP0555649A2 Gene encoding transglutaminase derived from fish |
08/18/1993 | EP0555449A1 Simultaneous shear and denaturation of nucleic acids |
08/18/1993 | EP0555435A1 DNA SEQUENCE ENCODING BOVINE $g(a)-LACTALBUMIN AND METHODS OF USE |
08/18/1993 | EP0555425A1 Antibodies to streptolysin o derivatives and variants |